A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy (2024)
DOI:
https://doi.org/10.56098/xncqaa94Keywords:
genetic experimentation on humans, human GMOs, human gut biota, lipid nanoparticles, COVID-19 modified mRNA vaccines, Moderna mRNA vaccine, Pfizer mRNA vaccine, self-assembling structuresAbstract
While Professor A. Ulrich (2024) raised justifiable questions about the interpretation of microscopic images from incubated COVID-19 injectables from Pfizer and Moderna, her message treats the world-wide genetic modification experiment with COVID-19 injectables on humans — an experiment on us without our consent — as normal. I will not discuss the physico-chemistry of the 10 trillion lipid nanoparticles she claims are in every dose of the injectables. She acknowledges that “many of the lipid constituents . . . tend to induce inflammation” (p. 1244.3) but says they account for all the self-assembling structures documented in what she describes as the “reliable” and “fully consistent” findings (Ulrich, p. 1244.7) of Lee and Broudy (2024). Though I believe the self-assembling structures also merit in-depth study, the technology underlying them, must be contained in the concoctions injected into the arms of two-thirds of the world’s population without proper preclinical testing and without the informed consent required by the Nuremberg Code. My focus is on that violation of medical ethics turning humans into genetically modified organisms. Here I illustrate in her words that such a genetic experiment on humans is underway. Instead of refuting any of the evidence in Lee and Broudy (2024) —that whatever the injectables may actually contain they are harming the human population of the world — she actually admits in closing that those “risks will be exacerbated with the next generation of self-amplifying or self-replicating RNA vectors for vaccines” (1244.8).
References
Benzi Cipelli, R., Giovannini, F., & Pisano, G. (2022). Dark-field microscopic analysis on the blood of 1,006 symptomatic persons after anti-COVID mRNA injections from Pfizer/BioNtech or Moderna. International Journal of Vaccine Theory, Practice, and Research, 2(2), 385–444. https://doi.org/10.56098/ijvtpr.v2i2.47
Cabanillas, B., Akdis, C. A., & Novak, N. (2021). COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?” Allergy, 76(6), 1938–1940. https://doi.org/10.1111/all.14725
Chen, S. P., & Blakney, A. K. (2024). Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics. Current Opinion in Biotechnology, 85, 103049. https://doi.org/10.1016/j.copbio.2023.103049
Children’s Health Defense. (2020, December 14). FDA Ignores RFK, Jr.’s Pleas for Vaccine Safety Oversight Concerning PEG, Suspected To Cause Anaphylaxis. https://www.prnewswire.com/news-releases/fda-ignores-rfk-jrs-pleas-for-vaccine-safety-oversight-concerning-peg-suspected-to-cause-anaphylaxis-301192173.html
Commissioner, O. of the. (2024). Emergency Use Authorization. FDA. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
European Commission. (2024). Q&A: Conditional Marketing Authorisation of COVID-19 Vaccine [Text]. European Commission - European Commission. https://ec.europa.eu/commission/presscorner/detail/en/qanda_20_2390
Ghebreyesus, T. A. (2020, March 11). WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023). A comprehensive review of mRNA vaccines. International Journal of Molecular Sciences, 24(3), Article 3. https://doi.org/10.3390/ijms24032700
Guetzkow, J. (2023, January 4). CDC Finally Released Its VAERS Safety Monitoring Analyses for COVID Vaccines via FOIA [Substack newsletter]. Jackanapes Junction. https://jackanapes.substack.com/p/cdc-finally-released-its-vaers-safety?publication_id=747747&isFreemail=true
Hughes, D. A. (2021). “COVID-19 vaccines” for children in the UK: A tale of establishment corruption. International Journal of Vaccine Theory, Practice, and Research, 2(1), 209–247. https://doi.org/10.56098/ijvtpr.v2i1.35
Hughes, D. A. (2022). What is in the so-called COVID-19 “vaccines”? Part 1: evidence of a global crime against humanity. International Journal of Vaccine Theory, Practice, and Research, 2(2), 455–586. https://doi.org/10.56098/ijvtpr.v2i2.52
Hughes, D. A. (2024). “COVID-19,” Psychological Operations, and the War for Technocracy: Volume 1. Springer International Publishing. https://doi.org/10.1007/978-3-031-41850-1
Kirsch, S., Marik, P., Rogers, C., Cosgrove, K., & Mead, M. N. (2024). A Novel Practical Approach for Directly Assessing COVID-19 Vaccine Efficacy against Hospitalization (2024080338). Preprints. https://doi.org/10.20944/preprints202408.0338.v1
Lee, Y. M., & Broudy, D. (2024). Real-time self-assembly of stereomicroscopically visible artificial constructions in incubated specimens of mRNA products mainly from Pfizer and Moderna: A comprehensive longitudinal study. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1180–1244. https://doi.org/10.56098/586k0043
Mead, M. N., Seneff, S., Rose, J., Wolfinger, R., McCullough, P. A., & Hulscher, N. (2024). COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1246–1315. https://doi.org/10.56098/w66wjg87
Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1112–1178. https://doi.org/10.56098/fdrasy50
Nance, K. D., & Meier, J. L. (2021). Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines. ACS Central Science, 7(5), 748–756. https://doi.org/10.1021/acscentsci.1c00197
Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US Vaccine Adverse Events Reporting System (VAERS) in association with COVID-19 injectable biological products. Current Problems in Cardiology, 101011. https://doi.org/10.1016/j.cpcardiol.2021.101011
Santiago, D. (2022). A partial answer to the question posed by David A. Hughes, PhD, in the article: “What is in the so-called COVID-19 ‘vaccines’? Part 1: evidence of a global crime against humanity.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 587–594. https://doi.org/10.56098/ijvtpr.v2i2.56
Seneff, S., & Nigh, G. (2021). Worse than the disease? Reviewing some possible unintended consequences of the mRNA vaccines against COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(1), 38–79. https://doi.org/10.56098/ijvtpr.v2i1.23
Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021. JAMA. https://doi.org/10.1001/jama.2021.1967
Smout, A. (2020, December 10). Britain issues anaphylaxis warning on Pfizer vaccine after adverse reactions. Japan Today. https://japantoday.com/category/world/Britain-issues-anaphylaxis-warning-on-Pfizer-vaccine-after-adverse-reactions
Sobczak, M., & Pawliczak, R. (2022). The risk of anaphylaxis behind authorized COVID-19 vaccines: A meta-analysis. Clinical and Molecular Allergy, 20(1), 1. https://doi.org/10.1186/s12948-022-00167-y
Tuuminen, T., Suominen, P. J., & Guldbrandsen, T. A. (2023). A Finnish Survey of Adverse Effects of COVID-19 Injectables and the Functionality of the Medical System. International Journal of Vaccine Theory, Practice, and Research, 3(1), 1009–1025. https://doi.org/10.56098/ijvtpr.v3i1.87
Ulrich, A. S. (2024). No Nanobots in Vaccines — Just Lipids on the Loose: Commentary on Lee and Broudy (2024), “Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study.” International Journal of Vaccine Theory, Practice, and Research, 3(2), 1244.1-1244.10. https://doi.org/10.56098/7hsjff81
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Tamara Tuuminen
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.